Isocitrate dehydrogenase gene mutations and 2-hydroxyglutarate accumulation in esophageal squamous cell carcinoma-Reference-Cited by-同舟云学术

Isocitrate dehydrogenase gene mutations and 2-hydroxyglutarate accumulation in esophageal squamous cell carcinoma

Published:2018-11-30 Issue:1 Volume:36 Page:
ISSN:1357-0560
Container-title:Medical Oncology
language:en
Short-container-title:Med Oncol

Author:

Miyake Keisuke,Baba Yoshifumi,Ishimoto Takatsugu,Hiyoshi Yukiharu,Iwatsuki Masaaki,Miyamoto Yuji,Yoshida Naoya,Watanabe Masayuki,Ogata Yoko,Nagayama Megumi,Silsirivanit Atit,Kobayashi Daiki,Araki Norie,Baba Hideo^ORCID

Funder

Japan Society for the Promotion of Science

Publisher

Springer Science and Business Media LLC

Subject

Cancer Research,Oncology,Hematology,General Medicine

Link

http://link.springer.com/article/10.1007/s12032-018-1229-x/fulltext.html

Reference34 articles.

1. Lehnert T. Multimodal therapy for squamous carcinoma of the oesophagus. Br J Surg. 1999;86(6):727–39.

2. Katlic MR, Wilkins EW Jr, Grillo HC. Three decades of treatment of esophageal squamous carcinoma at the Massachusetts General Hospital. J Thorac Cardiovasc Surg. 1990;99(5):929–38.

3. Flamen P, Van Cutsem E, Lerut A, et al. Positron emission tomography for assessment of the response to induction radiochemotherapy in locally advanced oesophageal cancer. Ann Oncol. 2002;13(3):361–8.

4. Brucher BL, Weber W, Bauer M, et al. Neoadjuvant therapy of esophageal squamous cell carcinoma: response evaluation by positron emission tomography. Ann Surg. 2001;233(3):300–9.

5. Downey RJ, Akhurst T, Ilson D, et al. Whole body 18FDG-PET and the response of esophageal cancer to induction therapy: results of a prospective trial. J Clin Oncol. 2003;21(3):428–32.

Cited by 4 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. A novel immune-related gene signature predicts survival in esophageal squamous cell carcinoma;Translational Cancer Research;2021-05

2. Wild-type IDH2 contributes to Epstein–Barr virus-dependent metabolic alterations and tumorigenesis;Molecular Metabolism;2020-06

3. mTORC1 as a Regulator of Mitochondrial Functions and a Therapeutic Target in Cancer;Frontiers in Oncology;2019-12-13

4. Integrative Analysis Reveals Comprehensive Altered Metabolic Genes Linking with Tumor Epigenetics Modification in Pan-Cancer;BioMed Research International;2019-11-07